These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 16223487

  • 1. Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione.
    Gayarre J, Stamatakis K, Renedo M, Pérez-Sala D.
    FEBS Lett; 2005 Oct 24; 579(25):5803-8. PubMed ID: 16223487
    [Abstract] [Full Text] [Related]

  • 2. Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro.
    Gayarre J, Avellano MI, Sánchez-Gómez FJ, Carrasco MJ, Cañada FJ, Pérez-Sala D.
    Ann N Y Acad Sci; 2007 Jan 24; 1096():78-85. PubMed ID: 17405918
    [Abstract] [Full Text] [Related]

  • 3. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton.
    Stamatakis K, Sánchez-Gómez FJ, Pérez-Sala D.
    J Am Soc Nephrol; 2006 Jan 24; 17(1):89-98. PubMed ID: 16291835
    [Abstract] [Full Text] [Related]

  • 4. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival.
    Sánchez-Gómez FJ, Gayarre J, Avellano MI, Pérez-Sala D.
    Arch Biochem Biophys; 2007 Jan 15; 457(2):150-9. PubMed ID: 17169324
    [Abstract] [Full Text] [Related]

  • 5. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
    Sánchez-Gómez FJ, Cernuda-Morollón E, Stamatakis K, Pérez-Sala D.
    Mol Pharmacol; 2004 Nov 15; 66(5):1349-58. PubMed ID: 15317873
    [Abstract] [Full Text] [Related]

  • 6. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective.
    Renedo M, Gayarre J, García-Domínguez CA, Pérez-Rodríguez A, Prieto A, Cañada FJ, Rojas JM, Pérez-Sala D.
    Biochemistry; 2007 Jun 05; 46(22):6607-16. PubMed ID: 17489560
    [Abstract] [Full Text] [Related]

  • 7. Study of protein targets for covalent modification by the antitumoral and anti-inflammatory prostaglandin PGA1: focus on vimentin.
    Gharbi S, Garzón B, Gayarre J, Timms J, Pérez-Sala D.
    J Mass Spectrom; 2007 Nov 05; 42(11):1474-84. PubMed ID: 17960581
    [Abstract] [Full Text] [Related]

  • 8. Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.
    Storer PD, Xu J, Chavis JA, Drew PD.
    J Neurosci Res; 2005 Apr 01; 80(1):66-74. PubMed ID: 15723383
    [Abstract] [Full Text] [Related]

  • 9. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells.
    Kim DH, Kim EH, Na HK, Surh YJ.
    Ann N Y Acad Sci; 2009 Aug 01; 1171():202-9. PubMed ID: 19723057
    [Abstract] [Full Text] [Related]

  • 10. The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras.
    Oliva JL, Pérez-Sala D, Castrillo A, Martínez N, Cañada FJ, Boscá L, Rojas JM.
    Proc Natl Acad Sci U S A; 2003 Apr 15; 100(8):4772-7. PubMed ID: 12684535
    [Abstract] [Full Text] [Related]

  • 11. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo.
    Kato T, Fukushima M, Kurozumi S, Noyori R.
    Cancer Res; 1986 Jul 15; 46(7):3538-42. PubMed ID: 3708585
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2.
    Kansanen E, Kivelä AM, Levonen AL.
    Free Radic Biol Med; 2009 Nov 01; 47(9):1310-7. PubMed ID: 19573595
    [Abstract] [Full Text] [Related]

  • 16. Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity.
    Díez-Dacal B, Gayarre J, Gharbi S, Timms JF, Coderch C, Gago F, Pérez-Sala D.
    Cancer Res; 2011 Jun 15; 71(12):4161-71. PubMed ID: 21507934
    [Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory activity of 15-deoxy-delta12,14-PGJ2 and 2-cyclopenten-1-one: role of the heat shock response.
    Ianaro A, Ialenti A, Maffia P, Di Meglio P, Di Rosa M, Santoro MG.
    Mol Pharmacol; 2003 Jul 15; 64(1):85-93. PubMed ID: 12815164
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification.
    Garzón B, Gayarre J, Gharbi S, Díez-Dacal B, Sánchez-Gómez FJ, Timms JF, Pérez-Sala D.
    Chem Biol Interact; 2010 Jan 05; 183(1):212-21. PubMed ID: 19800325
    [Abstract] [Full Text] [Related]

  • 20. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
    Ciucci A, Gianferretti P, Piva R, Guyot T, Snape TJ, Roberts SM, Santoro MG.
    Mol Pharmacol; 2006 Nov 05; 70(5):1812-21. PubMed ID: 16908599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.